A metabolic profiling analysis of symptomatic gout in human serum and urine using high performance liquid chromatography-diode array detector technique

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2132-2140

  Liu, Yun ^a,b   Sun, Xiaoming ^a,b   Di, Duolong ^a   Quan, Jinxing ^c   Zhang, Juan ^d   Yang, Xiaofang ^e  

^a LANZHOU INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Gansu Province People Hospital   (China)

^d LANZHOU UNIVERSITY   (China)

^e Gansu Province Hospital of Traditional Chinese Medicine   (China)

Author keywords

Biomarker; Gout; High performance liquid chromatography diode array detector; Metabolic profiling analysis; Metabonomics

Indexed keywords

CREATININE; GUANOSINE; HIPPURIC ACID; TRYPTOPHAN; URIC ACID;

ANALYTIC METHOD; ARTICLE; BLOOD; CONTROLLED STUDY; GOUT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY DIODE ARRAY DETECTOR; HUMAN; METABOLOMICS; ORTHOGONAL SIGNAL PARTIAL LEAST SQUARES REGRESSION DISCRIMINATE ANALYSIS; PH; PRECIPITATION; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; SCREENING TEST; URINE; VALIDITY;

ADULT; AGED; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GOUT; HUMANS; MALE; MIDDLE AGED;

EID: 80053654910     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.07.031     Document Type: Article

References (40)

1. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
2. Greef J., Hankemeier T., McBurney R.N. Metabolomics-based systems biology and personalized medicine: moving towards n=1 clinical trials?. Pharmacogenomics 2006, 7:1087-1094.
3. Nicholson J.K., Homes E., Lindon J.C., Wilson I.D. The challenges of modeling mammalian biocomplexity. Nat Biotechnol 2004, 22:1268-1274.
4. Dai H., Xiao C.N., Liu H.B., Hao F.H., Tang H.R. Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia Miltiorrhiza Bunge. J Proteome Res 2010, 9:1565-1578.
5. Yang J., Xu G.W., Zheng Y.F., Kong H.W., Pang T., Lv S., et al. Diagnosis of liver cancer using HPLC-based metabonomics in the aim to avoid the false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B 2004, 813:59-65.
6. Tang H.R., Wang Y.L. Metabonomics-a revolution in progress. Prog Biochem Biophys 2006, 33:401-417.
7. Wilson I.D., Plumb R., Granger J., Major H., Williams R., Lenz E.M. HPLC-MS-based methods for the study of metabonomics. J Chromatogr B 2005, 817:67-76.
8. Eggebeen A.T. Gout: an update. Am Fam Physician 2007, 76:801-808.
9. Wallace S.L., Robinson H., Masi A.T., Decker J.L., McCarty D.J., Yu T.F. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895-900.
10. Guggi V., Calame L., Gerster J.C. Contribution of digit joint aspiration to the diagnosis of rheumatic diseases. Joint Bone Spine 2002, 69:58-61.
11. Perez-Ruiz F., Naredo E. Imaging modalities and monitoring measures of gout. Curr Opin Rheumatol 2007, 19:128-133.
12. Bloch C., Hermann G., Yu T.F. A radiologic reevaluation of gout: a study of 2,000 patients. Am J Roentgenol 1980, 134:781-787.
13. Dieppe P.A., Swan A. Identification of crystals in synovial fluids and joint tissues. Ann Rheum Dis 1999, 58:261-263.
14. Pak C.Y.C., Sakhaee K., Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 1986, 30:422-428.
15. Nobeli I., Ponstingl H., Krissinel E.B., Thornton J.M. A structure-based anatomy of the E. coli metabolome. J Mol Biol 2003, 334:697-719.
16. Nicholson J.K., Wilson I.D. High resolution proton magnetic resonance spectroscopy of biological fluids. NMR Spectrosc 1989, 21:449-501.
17. Lenz E.M., Wilson I.D. Analytical strategies in metabonomics. J Proteome Res 2007, 6:443-458.
18. Li X., Xu Z.L., Lu X., Yang X.H., Yin P.Y., Kong H.W., et al. Comprehensive two-dimensional gas chromatography/ time-of-flight mass spectrometry for metabonomics: biomarker discovery for diabetes mellitus. Anal Chim Acta 2009, 633:257-262.
19. Kaspar H., Dettmer K., Gronwald W., Oefner P.J. Automated GC-MS analysis of free amino acids in biological fluids. J Chromatogr B 2008, 870:222-232.
20. Tuan H.P., Kaskavelis L., Daykin C.A., Janssen H.G. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. J Chromatogr B 2003, 789:283-301.
21. Dettmer K., Aronov P.A., Hammock B.D. Mass spectrometry-based metabolomics. Mass Spectrom Rev 2007, 26:51-78.
22. Porcu S., Corda M., Lilliu F., Contini L., Era B., Traldi P., et al. Increase in urinary purines and pyrmidines in patients with methylmalonic aciduria combined with homocystinuria. Clin Chim Acta 2010, 411:853-858.
23. Yamamoto H., Hada K., Yamaji H., Katsuda T., Ohno H., Fukuda H. Application of regularized alternating least squares and independent component analysis to HPLC-DAD data of Haematococcus pluvialis metabolites. Biochem Eng J 2006, 32:149-156.
24. Plaza M., Santoyo S., Jaime L., Reina G.G.B., Herrero M., Senorans F.J., et al. Screening for bioactive compounds from algae. J Pharm Biomed Anal 2010, 51:450-455.
25. Sun XM, Liu Y, Di DL, Wu GT, Guo HY Chemometric analysis of metabolism disorders in blood plasma of S180 and H22 tumor-bearing mice by high performance liquid chromatography-diode array detection. J Chemom 2011, 25:430-440.
26. Bijlsma S., Bobeldijk I., Verheij E.R., Ramaker R., Kochhar S., Macdonald I.A., et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 2006, 78:567-574.
27. Noda I. Scaling techniques to enhance two-dimensional correlation spectra. J Mol Struct 2008, 883:216-227.
28. Want E.J., O'Maille G., Smith C.A., Brandon T.R., Uritboonthai W., Qin C., et al. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem 2006, 78:743-752.
29. Gavaghan C.L., Wilson I.D., Nicholson J.K. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett 2002, 530:191-196.
30. Wiklund S., Johansson E., Sjostrom L., Wellerowicz E.J., Edlund U., Shockcor J.P., et al. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 2008, 80:115-122.
31. Yang Q., Shi X.Z., Wang Y., Wang W.Z., He H.B., Lu X., et al. Urinary metabonomic study of lung cancer by a fully automatic hyphenated hydrophilic interaction/RPLC-MS system. J Sep Sci 2010, 33:1495-1503.
32. Eriksson L., Johansson E., Kettaneh-Word N., Wold S. Umetrics 2001.
33. Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 2010, 233:218-232.
34. Richette P. Gout. T Lancet 2009, 375:318-328.
35. Ayvazian J.H., Ayvazian L.F. Changes in serum and urinary uric acid with the development of symptomatic gout. J Clin Invest 1963, 42:1835-1837.
36. Gutman A.B., Yu T.F. Renal function in gout with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout. Am J Med 1957, 23:600-602.
37. Bratty MA, Hobani Y, Dow JAT, Watson DG. Metabolomic profiling of the effects of allopurinol on Drosophila melanogaster. Metabolomics in press, doi:. doi:10.1007/s11306-011-0275-6.
38. Stetten D.J. Gout. Perspect Biol Med 1959, 2:185-196.
39. Puig J.G., Anton F.M., Jimenez M.L., Gutierrez P.C. Renal handling of uric acid in gout: impaired tubular transport of urate not dependent on serum urate levels. Metabolism 1986, 35:1147-1153.
40. Puig J.G., Mateos F.A., Jimenez M.L., Ramos T.H. Renal excretion of hypoxantine and xantine in primary gout. Am J Med 1988, 85:533-537.